Assessing Increases in Cannabis-Related Diagnoses in US Hospitals by Regional Policy Status.

Autor:	Pottieger M; Department of Public Health and College of Health Sciences, Arcadia University, Philadelphia, Pennsylvania, USA.; Department of Medical Science, College of Health Sciences, Arcadia University, Philadelphia, Pennsylvania, USA., Rowland L; College of Population Health, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., DiSantis KI; College of Population Health, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jazyk:	angličtina
Zdroj:	Population health management [Popul Health Manag] 2022 Dec; Vol. 25 (6), pp. 738-743. Date of Electronic Publication: 2022 Oct 10.
DOI:	10.1089/pop.2022.0122
Abstrakt:	Cannabis policy is rapidly changing and more individuals are using cannabis nationally. Despite increased use and known adverse outcomes to cannabis use, there is a lack of understanding of health care utilization for cannabis-related conditions. The objectives of this study were: (1) To understand the change in the incidence of cannabis-related diagnoses from 2012 to 2015 nationally and (2) to describe the relationship between regional cannabis policies and changes in the incidence of cannabis-related diagnoses from 2012 to 2015. National Inpatient Sample (NIS) data from the Healthcare Cost and Utilization Project for 2012 and 2015 were analyzed using SPSS software for incidence of cannabis diagnoses. Previously defined NIS regions were assigned a policy status related to medical and recreational cannabis laws. Comparisons were made at the national and regional levels to better understand change in incidence of diagnoses. From 2012 to 2015, there was a 26.7% increase in cannabis-related diagnoses in the inpatient setting nationally. All 9 regions showed increases in the incidence of cannabis-related diagnoses ranging from 15.5% to 41.9% regardless of cannabis policy. As cannabis policy increased legal access, cannabis-related diagnoses increased nationally and regionally across the United States from 2012 to 2015 regardless of cannabis policy. Continued tracking of cannabis-related diagnoses is needed to identify where interventions are necessary to reduce negative impacts of increased cannabis use.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu